|
|
||||||||
1 From the INSERM U-393, Hôpital des EnfantsMalades, Paris; and the 2 Clinique Ophthamologique Universitaire de Créteil, Créteil, France.
| Abstract |
|---|
|
|
|---|
METHODS. A complete ophthalmological examination including visual acuity measurement, fundus examination, and fluorescein angiography (FA) was performed on each exudative AMD patient. The entire coding sequence of the ABCR gene was analyzed using a combination of single-strand conformation polymorphism and confirmatory sequencing of the exons showing an abnormal pattern of migration.
RESULTS. Six heterozygous missense changes were identified. A lack of familial segregation was observed in 4 of 6 codon changes (Arg943Gln, Val1433Ile, Pro1948Leu, and Ser2255Ile). Conversely, 2 codon changes cosegregated with the disease in 2 small families: Pro940Arg and Leu1970Phe.
CONCLUSIONS. The authors believe that segregation of the ABCR gene mutations with familial cases of AMD has not yet been shown. The analysis of familial segregation allowed the authors to exclude 4 of 6 codon changes as disease-causing mutations. Furthermore, it was shown here that the ABCR gene may be rarely involved in exudative AMD, with at best 2 of 52 familial cases (4%) related to this susceptibility factor.
| Introduction |
|---|
|
|
|---|
4 allele of the apoE gene in exudative AMD,
and, finally, linkage to chromosome 1q in a large family give strong
support for the hypothesis of a genetically determined disease
triggered by environmental stimuli.4
5
6
7
8
9
10
11
12
13 Mutations in the Stargardt disease gene (ABCR) have been previously reported in patients with Stargardt disease, fundus flavimaculatus, and retinitis pigmentosa (RP19) and in some cases of cone-rod dystrophy.14 15 16 17 18 19 20 21 22 23 24 In 1997, Allikmets and colleagues identified 13 mutant alleles of the ABCR gene in 16% (26/167) of atrophic AMD patients,19 but the relevance of ABCR gene mutations in AMD has been questioned.25 26 27 Nevertheless, the hypothesis of whether some ABCR alleles may increase the risk of AMD has to be considered even if a simple cause-and-effect relationship is unlikely. Our purpose was to analyze the segregation of mutations in familial cases of exudative AMD, but not to realize a case-control study as already performed.19 25 26 27
| Methods |
|---|
|
|
|---|
ABCR Gene Analysis
We analyzed the entire coding sequence of the ABCR gene
using a combination of single-strand conformation polymorphism (SSCP)
and direct sequence analysis of each exon. For SSCP analysis, the
entire coding region, and approximately 30 bp of intron sequence
adjacent to each of the 50 exons, was analyzed, using the previously
described primers.28
The DNA (100 ng) from peripheral
blood leukocytes was amplified using specific primers and 0.1 µl of
(
-33)d-CTP (10 mCi/ml) in a 25 µl amplification mixture
containing 10 mM TrisHCl (pH 8.3), 50 mM KCl, 1.5 mM
MgCl2, 0.2 mM dNTP, and 0.5 U Taq
polymerase. The annealing temperature was adjusted for each exon.
Amplified DNA (6 µl) was mixed with an equal volume of formamide
loading dye (95% formamide, 20 mM EDTA, 0.005% bromophenol blue,
0.05% xylene cyanol). The samples (5 µl) were denatured for 10
minutes at 95°C, loaded onto a polyacrylamide gel (20 x 45 x 0.04 cm), and electrophoresed at 4 W for 18 hours at room
temperature in 0.6x TBE running buffer. Gels were transferred onto
Whatman paper, dried, and autoradiographed with Kodak X-OMAT film for
24 hours. Exons that displayed conformational polymorphism were
sequenced on an automatic fluorometric DNA sequencer. The PCR fragments
were excised from a low-melting-point gel (GTG NuSieve). Direct
sequencing was performed on single-strand DNA, produced by asymmetrical
PCR using the amplification primers as sequencing primers.
Familial Analysis
When examination of the siblings of our patients was not possible
at our clinic, blood samples and the FA pictures were obtained.
Segregation of nucleotide substitution identified in patients has been
carefully studied in relatives of the AMD patients. Only alive members
older than 55 years of age were analyzed. In a large family, linkage
analysis has been performed using the MLINK and LINKMAP options of
version 5.1 of the LINKAGE program.29
Controls
The nucleotide substitutions observed in this screening were
researched by SSCP analysis in a control population, obtained from 90
unrelated French individuals without any complaint of visual
impairment. Our control group was not age- or sex-matched, and no
ophthalmological examination was performed for these individuals.
| Results |
|---|
|
|
|---|
The Arg943Gln, Pro1948Leu, and Ser2255Ile substitutions were observed in the control group: in 3 of 90, 3 of 90, and 1 of 90, respectively. Conversely, the Pro940Arg, Val1433Ile, and Leu1970Phe changes were not found in the control group.
No cosegregation of the base substitution with the disease was observed
in the families harboring either Arg943Gln, Val1433Ile, Pro1948Leu, or
Ser2255Ile changes. Indeed, the substitutions were present in some
unaffected individuals and absent in some relatives affected with AMD.
It is worth noting that the Pro1948Leu codon change seen in a patient
belonging to a large family (13 siblings were alive and analyzed) did
not segregate with the disease. Moreover, linkage analysis performed
with polymorphic markers flanking the ABCR locus (D1S424,
D1S2868, D1S236) allowed us to definitely exclude this gene as a
disease-causing gene (data not shown). Conversely, a simulation
test give a maximal lod score for this family equal to 2.45 at
= 0.
An association of the mutations with the disease was observed in the 2 small families harboring 2 mutations absent in controls: Pro940Arg and Leu1970Phe (Fig. 1) . Clinical reports including age, age at onset of symptoms, visual acuity, fundus appearance, and FA features of all members of these 2 families are shown in Table 1 .
|
|
| Discussion |
|---|
|
|
|---|
Since the initial publication of Allikmets and colleagues,19 there have been several rebuttals,25 26 27 criticizing the initial results and demonstrating contradictory statistical data, in case-control studies. In these studies, the Arg943Gln and Ser2255Ile codon changes have been reported as polymorphisms. Here, the lack of detection of Arg943Gln, Pro1948Leu, and Ser2255Ile in controls was not particularly meaningful and did not permit us to establish statistical significance.
The use of familial cases is an important strategy in understanding the potential contribution of gene alterations with respect to a genetically heterogeneous disorder. Certainly, if AMD is caused by specific alterations in the ABCR gene and if these alterations are felt to be sufficient to cause the disorder, then segregation within AMD families is a crucial prerequisite test. Analysis of the familial segregation showed 2 different sets of cases. First, a lack of segregation was observed, for the Arg943Gln, Val1433Ile, Pro1948Leu, and Ser2255Ile changes. Unaffected siblings carrying one of these codon changes were observed. It cannot be ruled out that some of these unaffected individuals might display an AMD some years later, because the risk of this multifactorial disease increases with age. However, for each of these 4 ABCR gene substitutions there were some siblings affected with AMD who did not carry the changes. The lack of association of an ABCR variant that is present in an AMD proband compared with a sibling does not totally exclude the possibility that the 2 individuals have different genetic etiologies for AMD. However, based on our findings, we support the hypothesis that the 4 missense substitutions were not disease-causing in these familial cases and could be considered as polymorphisms. It is worth noting that Val1433Ile, not observed in controls, was excluded only using segregation analysis.
Second, for Pro940Arg and Leu1970Phe we observed possible segregation with AMD. However, the families were too small to draw any definite conclusions about causality because only one generation could be analyzed. It is possible that the siblings harboring these changes were affected with AMD only by chance, regarding the high frequency of the disease. On the other hand, we can also entertain the idea that these 2 ABCR gene missense substitutions confer an increased risk for AMD. The Pro940Arg and the Leu1970Phe codon changes occur in codons adjacent to the first and second ATP-binding sites, respectively. However, in the absence of a functional assay for the ABCR protein, we cannot state explicitly how the mutated alleles could affect the protein. The Leu1970Phe mutation has been observed in compound heterozygous Stargardt patients so that this mutation is presumed to induce important ABCR protein alterations.18 This mutation was also previously identified in one case of AMD but not observed in the general population (n = 220).19 To the best of our knowledge, the Pro940Arg mutation has not been reported previously.
We selected familial cases to increase our chances of showing meaningful ABCR gene mutations, but at best 2 of 52 familial cases (4%) could be related to this potential susceptibility factor. Because the sensitivity of SSCP is between 80% and 90%, it is possible that a few additional mutations may have escaped detection by our SSCP screening.30 31 Nevertheless, it seems clear that the ABCR gene is involved to only a small degree in the familial cases of exudative AMD.
In the "ABCR controversy," the main point of discussion concerns the statistical comparison of codon change frequencies between AMD and control groups. Interestingly, the analysis of segregation of ABCR gene mutations in familial cases of AMD appears to be an alternative way. Indeed, it allowed us to exclude 4 of 6 missense changes as disease-causing mutations. Furthermore, in contrast with atrophic forms of AMD,19 the exudative forms of AMD seem rarely to be associated with ABCR gene mutations. This could explain in part the contradictory data about ABCR variant frequencies in AMD.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication March 23, 1999; revised July 28, 1999; accepted August 27, 1999.
Commercial relationships policy: N.
Corresponding author: Gisèle Soubrane, Clinique Ophthamologique Universitaire de Créteil, 40 Avenue de Verdun, 94010 Créteil, France. soubranegisele{at}europost.com
| References |
|---|
|
|
|---|
4 allele of the apoE gene as a potential protective factor for exudative age-related macular degeneration Am J Ophthalmol 125,353-359[Medline][Order article via Infotrieve]
This article has been cited by other articles:
![]() |
S. Schmidt, E. A. Postel, A. Agarwal, I. C. Allen Jr, S. N. Walters, M. A. De La Paz, W. K. Scott, J. L. Haines, M. A. Pericak-Vance, and J. R. Gilbert Detailed Analysis of Allelic Variation in the ABCA4 Gene in Age-Related Maculopathy Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2868 - 2875. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Danciger, J. Lyon, D. Worrill, M. M. LaVail, and H. Yang A Strong and Highly Significant QTL on Chromosome 6 that Protects the Mouse from Age-Related Retinal Degeneration Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2442 - 2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Hall, C. R. Gale, H. Syddall, C. N. Martyn, and D. I. W. Phillips Relation between Size at Birth and Risk of Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., December 1, 2002; 43(12): 3641 - 3645. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukui, S. Yamamoto, K. Nakano, M. Tsujikawa, H. Morimura, K. Nishida, N. Ohguro, T. Fujikado, M. Irifune, K. Kuniyoshi, et al. ABCA4 Gene Mutations in Japanese Patients with Stargardt Disease and Retinitis Pigmentosa Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2819 - 2824. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suarez, S. B. Biswas, and E. E. Biswas Biochemical Defects in Retina-specific Human ATP Binding Cassette Transporter Nucleotide Binding Domain 1 Mutants Associated with Macular Degeneration J. Biol. Chem., June 7, 2002; 277(24): 21759 - 21767. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Bernstein, M. Leppert, N. Singh, M. Dean, R. A. Lewis, J. R. Lupski, R. Allikmets, and J. M. Seddon Genotype-Phenotype Analysis of ABCR Variants in Macular Degeneration Probands and Siblings Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 466 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
B J. Klevering, M. van Driel, A. J M van Hogerwou, D. J R van de Pol, A. F Deutman, A. J L G Pinckers, F. P M Cremers, and C. B Hoyng Central areolar choroidal dystrophy associated with dominantly inherited drusen Br. J. Ophthalmol., January 1, 2002; 86(1): 91 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. K. Klein, R. Klein, K. E. Lee, E. L. Moore, and L. Danforth Risk of Incident Age-related Eye Diseases in People with an Affected Sibling : The Beaver Dam Eye Study Am. J. Epidemiol., August 1, 2001; 154(3): 207 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G Sauer, K. White, H. Stohr, T. Grimm, A. Hutchinson, P. S Bernstein, R. A. Lewis, F. Simonelli, D. Pauleikhoff, R. Allikmets, et al. Evaluation of the G protein coupled receptor-75 (GPR75) in age related macular degeneration Br. J. Ophthalmol., August 1, 2001; 85(8): 969 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Mata, R. T. Tzekov, X. Liu, J. Weng, D. G. Birch, and G. H. Travis Delayed Dark-Adaptation and Lipofuscin Accumulation in abcr+/- Mice: Implications for Involvement of ABCR in Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1685 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Guymer, E. Heon, A. J. Lotery, F. L. Munier, D. F. Schorderet, P. N. Baird, R. J. McNeil, H. Haines, V. C. Sheffield, and E. M. Stone Variation of Codons 1961 and 2177 of the Stargardt Disease Gene Is Not Associated With Age-Related Macular Degeneration Arch Ophthalmol, May 1, 2001; 119(5): 745 - 751. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |